Hemophilia Mobile App Usability Pilot

Not Applicable

• Conditions: Hemophilia
• Interventions: Device: SureSource Engage application

• Registration Number: NCT03168685
• Lead Sponsor: Healthcare Innovation Technology Lab

Brief Summary

The purpose of this study is to evaluate the utility and user experience of a smart phone app for people with medical conditions, used in conjunction with an ActiGraph wearable device and a connected scale.

Detailed Description

HITLAB will conduct a segmented rapid user acceptance study ("rapid UX study") of a smart phone app and an actigraphy device with a connected scale. During the first segment, of one month's duration, subjects will use the app, actigraphy device, and scale. Next, over an interphase period of up to 6 weeks, subjects will only use the app. During this time, the app will be modified based on data collected during the first segment. Finally, during the second period, also of one month's duration, subjects will use the modified app, actigraphy device, and scale.

Study Timeline

• Study Start: 2017-05-22
• Study First Submitted: 2017-05-23
• Study First Submitted QC: 2017-05-25
• Study First Posted: 2017-05-30
• Status Verified: 2018-04
• Last Update Submitted: 2018-04-17
• Last Update Posted: 2018-04-19
• Primary Completion: 2018-05-11
• Study Completion: 2018-05-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. You own an iPhone or a Samsung (S5 or higher) smartphone
2. Your age is between 18 and 63 years
3. You reside in the New York metropolitan area
4. You are able to read, write, and speak English
5. You have participated in a concluded clinical trial in the past two years

Exclusion Criteria

1. You do not own an iPhone or a Samsung (S5 or higher) smartphone
2. Your age is not between 18 and 63 years
3. You do not reside in the New York metropolitan area
4. You are not able to read, write, and speak English
5. You have not participated in a concluded clinical trial in the past two years

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Experimental	SureSource Engage application	Multiple device intervention 1. SureSource Engage mobile application 2. ActiGraph Link 3. weight scale

Primary Outcome Measures

Name	Time	Method
Device usability as assessed by the System Usability Scale (SUS)	128 days
Usage of the SureSource Engage application as assessed by ActiLife software	128 days

Trial Locations

Locations (1)

Healthcare Innovation and Technology Lab; 🇺🇸 New York, New York, United States